This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Clorox Stock Trades Below 200 & 50-Day SMA: How to Play the Stock?
by Zacks Equity Research
CLX navigates cost challenges while driving growth through strategic investments, innovation and global expansion.
Why Is Clorox (CLX) Up 1.7% Since Last Earnings Report?
by Zacks Equity Research
Clorox (CLX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Clorox's IGNITE Plan & Other Strategic Efforts Progress Well
by Zacks Equity Research
CLX benefits from robust pricing and cost-saving initiatives. The company's IGNITE strategy also bodes well.
Procter & Gamble Trades Above 50 & 200-Day SMAs: Buy Now or Wait?
by Rajani Lohia
PG drives growth through productivity and cost savings but faces headwinds from geopolitical tensions, currency volatility and challenges in key markets.
Clorox Stock Falls 7.2% Post Q2 Earnings: Time to Buy or Hold?
by Zacks Equity Research
CLX faces near-term pressure from weak earnings and ongoing operational transitions, but its long-term strategy bodes well.
Clorox Beats Q2 Earnings & Sales Estimates, Updates FY25 Outlook
by Zacks Equity Research
CLX's Q2 results reflect strong core fundamentals, market share gains and gross margin expansion amid cyberattack recovery and divestitures.
Clorox (CLX) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
by Zacks Equity Research
The headline numbers for Clorox (CLX) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Clorox (CLX) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Clorox (CLX) delivered earnings and revenue surprises of 11.51% and 3.12%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Markets React to Softening Trade Tariff Policy
by Mark Vickery
An almost immediate retraction of a 25% tariff on imported goods from Mexico prodded this relief trade.
Pre-Markets in the Red on Trade War Fears
by Zacks Equity Research
Pre-Markets in the Red on Trade War Fears
Trade War Reality Sets into Pre-Markets
by Mark Vickery
The Dow has so far shed -600 points, the S&P 500 is -100 and the tech-heavy Nasdaq is -400 points at this hour.
Philip Morris' Q4 Earnings on Deck: Key Factors to Understand
by Zacks Equity Research
PM's Q4 results are likely to reflect gains from pricing and smoke-free strength amid volatile currency movements.
Kellanova Set to Release Q4 Earnings: Should You Expect a Beat?
by Zacks Equity Research
K's fourth-quarter results are likely to reflect gains from strategic pricing actions and cost-saving efforts.
Post Holdings' Q1 Earnings on Deck: Key Factors to Understand
by Zacks Equity Research
POST's Q1 results are likely to reflect strength in the Foodservice segment while showing concerns related to escalated advertising costs.
Kenvue (KVUE) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release
by Zacks Equity Research
Kenvue (KVUE) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
How to Find Strong Consumer Staples Stocks Slated for Positive Earnings Surprises
by Zacks Equity Research
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Mondelez Gears Up for Q4 Earnings: Here's What You Should Know
by Zacks Equity Research
MDLZ's fourth-quarter results are likely to reflect strength in core categories, while cocoa cost inflation is a concern.
EL Gears Up for Upcoming Q2 Earnings: Here's What You Should Know
by Zacks Equity Research
The Estee Lauder Companies' fiscal second-quarter results are likely to reflect the adverse impact of weakness across China and Asia travel retail.
Is Tyson Foods Up for an Earnings Beat in Its Q1 Earnings Release?
by Zacks Equity Research
TSN's Q1 results are likely to reflect gains from its chicken and prepared foods segments despite facing volume-related issues in the beef sector.
Colgate Stock Sees Strong Momentum Pre-Q4 Earnings: Time to Invest?
by Zacks Equity Research
CL's Q4 results are expected to reflect gains from pricing, funding-the-growth and other productivity initiatives, supporting strong business momentum.
Clorox Gears Up for Upcoming Q2 Earnings: Here's What You Should Know
by Zacks Equity Research
CLX is poised for growth as its IGNITE Strategy drives innovation, efficiency and international expansion amid a challenging market.
Is Church & Dwight Up for an Earnings Beat in Its Q4 Release?
by Zacks Equity Research
CHD's Q4 results are likely to reflect gains from brand strength and pricing power in a dynamic consumer environment.
Clorox Trading Above 200-Day SMA: Is the Stock Worth Buying?
by Zacks Equity Research
CLX looks poised for growth through recent recovery, improved distribution channels and focus on innovation and expansion despite facing some cost challenges.
Clorox (CLX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
by Zacks Equity Research
Clorox (CLX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
4 Consumer Staple Stocks Likely to Top Earnings Estimates This Season
by Vrishali Bagree
Companies with solid brands and efficient cost-management efforts are poised to shine amid a dynamic consumer landscape. KMB, CHD, CLX and KVUE are in focus.